HIMSS TV
Recruiting volunteers for nursing groups isn’t always easy, but networking and identifying people who want to share knowledge are worthy benefits, says Julie Luengas, chief nursing informatics officer at Stony Brook Medicine Information Technology.
Anurag Mehta, Omega Healthcare CEO, says using LLMs to analyze claim denial letters and create tailored appeals can drive efficiency, but humans must always be in the loop to approve or edit the resulting documents.
In addition to HIMSS25 Europe, Hal Wolf, HIMSS president and CEO, says HIMSS has partnered with Informa on the WHX Tech conference in Dubai and is actively working with the WHO and the EC to help "redesign" European digital health.
HIMSS25 Changemaker awardee Dr. Roosevelt De Los Santos explains how his work at Trinity Health to help clinicians, patients and staff embrace and understand technology contributes to advancing HIMSS' goal of transforming health.
Cardiac-focused caption guidance technology, which directs an ultrasound technician on where to place a probe to get the best image, is proving its worth, says Vaishali Kamat, GE HealthCare's GM of new ventures for ultrasound digital solutions.
MedGemma, built on Gemma 3, aims to help developers build AI-based healthcare applications with open models, including multimodal and text-only versions.
HIMSS benchmarks were used as guidance for advancing digital health maturity by Dr. Maheshwara Rao Appannan of Malaysia's Ministry of Health. The goals were increasing health equity and economic gains while improving patient outcomes.
New research from TrustCommerce show that, while debit cards remain popular and can be cheaper for health systems to accept, many patients would rather pay for treatment digitally. Ryne Natzke, the company's chief revenue officer, explains.
HIMSS supported and empowered Michigan Department of Health and Human Services' Krystal Schramm, a Changemaker Awardee, to work with others to establish the HIMSS Native American and Indigenous Community.
Gene and cell therapies can "reprogram" patients' own cells to stop the progression of certain cancers and genetic conditions in some situations, with remission rates of up to 92%, says Boro Dropulić, executive director of Caring Cross.